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Abstract
Introduction: Tissue oxygen saturation (StO2) and the vascular
occlusion test (VOT) can identify tissue hypoperfusion in trauma
and sepsis. However, the technique is neither standardized nor
uses the same monitoring site. We hypothesized that baseline and
VOT StO2 would be different in the forearm (F) and thenar
eminence (TH) and that different minimal StO2 values during the
VOT would result in different reoxygenation rates (ReO2).
Methods: StO2 and its change during the VOT were simul-
taneously measured in the F and TH, with 15 mm and 25 mm
probes, using the 325 InSpectra monitor in 18 healthy, adult
volunteers. Two VOTs were done to a threshold thenar StO2 of
40% interchanging the 15 mm and 25 mm probes between sites.
Two additional VOTs were done to thresholds of 50% and 30%.
Baseline StO2 (BaseO2), the deoxygenation rate (DeO2) and ReO2
(%O2/minute) were compared between sites, probes and
thresholds. Results are presented as the median (interquartile
range), P-value.
Results: BaseO2, DeO2, ReO2, area under the curve and
hyperemia duration values were different when comparing TH vs. F
and 15 mm vs. 25 mm probes. ReO2 was different between
different thresholds for the TH and 15 mm probes. TH15 mm vs.
F15 mm: BaseO2, 90.4 (85.2, 93.5) vs. 85.2 (80.7, 90.2), P = 0.031;
DO2, –12.1 (–16.2, –11.3) vs. –8.5 (–10.3, –7.8), P = 0.011;
ReO2, 297.2 (213.7, 328.6), P <0.0001; 15 mm vs. 25 mm probe:
BaseO2, 97.2 (89.4, 94.7) vs. 87.3 (81.7, 90.9), P = 0.016; DeO2,
–18.0 (–24.1, –14.8) vs. –9.9 (–15.3, –6.5), P <0.0001; and
ReO2, 401.6 (331.7, 543.2) vs. 160.5 (132.3, 366.9), P = 0.012,
respectively. TH15 mm vs. TH25 mm: BaseO2,  P  = 0.020; DeO2,
P <0.0001; and ReO2, P <0.0001. Threshold StO2 values (15 mm
probe only): ReO2, P = 0.003; DeO2, P = 0.60. ReO2 at 40% and
50% StO2 thresholds, P = 0.01.
Conclusion: BaseO2, DeO2 and ReO2 were different when
measured in different anatomical sites (F and TH) and with different
probe sizes, and ReO2 was different with differing VOT release
StO2 threshold values. Thus, standardization of the site, probe and
VOT challenge need to be stipulated when reporting data.
Introduction
Non-invasive measurements of tissue oxygen saturation
(StO2) using near-infrared spectroscopy have been studied
to assess tissue hypoperfusion in different populations. The
absolute StO2 has been proven instrumental in predicting
outcome in trauma patients [1,2]. These same studies,
however, have shown limited discriminating capacity for the
absolute StO2 value (sensitivity, 78%; specificity, 39%) and
have even shown it to be at least as good as systolic blood
pressure (sensitivity, 74%; specificity, 32%) [1]. The addition
of a provocative test (ischaemic challenge) to the measure-
ment of the StO2 would potentially enhance this discrimi-
natory power between different cardiovascular states by
creating emerging parameters to follow, such as the deoxyge-
nation and reoxygenation slopes. Furthermore, the use of
such provocative tests [3], specifically the vascular occlusion
test (VOT), has been shown to improve and expand the
predictive ability of StO2 to scenarios such as trauma, severe
sepsis and septic shock [4,5].
The VOT is a provocative test in which StO2 is measured on
a distal site (such as the thenar eminence (TH)) whilst a
transient rapid vascular occlusion is performed, using a
sphygmomanometer, for either a defined time interval (for
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example, 3 minutes) or until the StO2 decreases to a defined
minimal threshold. Once this threshold is reached, the
vascular occlusion is released and the StO2 is allowed to
recover. Several emergent parameters arise from this
technique, including the rate of deoxygenation (DeO2),
thought to reflect the local metabolic rate, the rate of
reoxygenation (ReO2), which reflects the time required to
wash out stagnant blood and is thought to be determined by
local cardiovascular reserve and microcirculatory flow, and
the postobstructive hyperemic response.
The VOT, however, has not been standardized. In fact, multiple
studies report results using different anatomical StO2 measuring
sites (TH, forearm (F), deltoid) [4,6-8], different near-infrared
spectroscopy probe sizes (15 mm vs. 25 mm) [4,8-12], and
different types and levels of deflation thresholds (StO2 of 40%,
50%) versus time thresholds (3 minutes, 4 minutes, 5 minutes)
[4,6,11,13]. Differences between anatomical sites may
potentially affect near-infrared spectroscopy-derived parameters
given the fact that fat and the muscle thickness distribution
along the body is variable. Furthermore, given that increasing
the sensing and illuminating probe distance augments the depth
that near-infrared light travels, the use of different probes may
screen different capillary beds at any given time. Finally, since
the primary reason to perform the VOT is to produce a transient
ischaemic challenge to note the subsequent ReO2, the level of
ischaemic challenge might vary for the same ischaemic time or
threshold StO2. As a consequence, caution must be taken
when comparing results from the available literature on the VOT,
as the test may be inadequate [14,15].
We hypothesized that absolute StO2 values and VOT-derived
StO2 values obtained by monitoring different anatomical sites
or using dissimilar depth may differ, and that different minimal
StO2 values during the VOT (deflation thresholds) would
result in dissimilar ReO2 rates.
Materials and methods
The present study was approved by the Institutional Review
Board of the University of Pittsburgh. Informed consent was
obtained from every volunteer enrolled in the study prior to
performing any procedure.
Near-infrared spectroscopy
StO2 and its change during the VOT were simultaneously
measured in the F and TH, with 15 mm and 25 mm probes,
using two 325 InSpectra® tissue spectrometers (Hutchinson
Technology Inc., Minneapolis, MN, USA) on the same arm in
18 healthy, adult volunteers. Placement of the TH probe was
done according to the manufacturer’s recommendations as
previously described [4,9]. The F probe was placed over the
Flexor digitorum profundus in the F.
Research software (InSpectra Version vBeta1.1; Hutchinson
Technology Inc.) on two independent laptop computers was
used for data collection.
Vascular occlusion test
The VOT was performed as previously described [9]. Briefly,
the baseline arterial pressure was measured using a manual
sphygmomanometer. An adult-size tourniquet cuff was then
placed on the arm above both probes. After StO2 signal
stabilization at rest (<2% variation in 30 seconds), the
tourniquet was inflated with an automatic pump (Portable
Tourniquet System, ref. 9-2100-001; Delfi Medical Innova-
tions Inc., Vancouver, BC, Canada) to >30 mmHg above
systolic pressure and was kept inflated until the StO2
decreased to 40% (deflation threshold). Inflation took approxi-
mately 3 to 4 seconds. The tourniquet was then rapidly
deflated (<0.5 seconds) and the StO2 response was
followed until the StO2 returned to baseline values. All
repeated VOTs were performed after a minimal period of
5 minutes to allow the StO2 to recover.
DeO2 and ReO2 slopes, the area under the curve of the
hyperemic response as well as the duration of hyperemia
(Figure 1) were calculated using the published methodology
and a software package designed for this purpose and this
specific tissue spectrometer (Version 3.03 InSpectra
Analysis Program; Hutchinson Technology Inc.), as previously
validated by us [9].
Protocol
Subjects were placed in a quiet environment while resting in
a semirecumbent position with the studied arm resting over a
cushion in the anatomical position. Probes were placed using
a form-fitting plastic adhesive over the TH and volar surface
Figure 1
Tissue oxygen saturation (StO2) during a vascular occlusion test.
Calculated parameters: deoxygenation rate (DeO2), reoxygenation rate
(ReO2), hyperemia area under the curve (AUC), and hyperemia
duration.of the F. The 15 mm probe was initially placed on the F and
the 25 mm probe placed on the TH. A VOT was then per-
formed. After a 5-minute resting period, the probe locations
were switched (that is, the 15 mm probe to the TH, and the
25 mm probe to the F) and a second VOT was performed.
Subsequently, two additional VOTs were carried out to StO2
deflation thresholds of 50% and 30% with the same probe
disposition.
Healthy volunteers
Volunteers were selected according to the following inclusion
and exclusion criteria: inclusion criterion, subjects older than
17 years (that is, ≥18 years); and exclusion criteria, acute or
chronic cardiovascular or pulmonary disease, or subject
taking any vasoactive medications.
Statistical analysis
Mean absolute StO2 values, the DeO2 and the ReO2
(%O2/minute) as measured by the 15 mm and 25 mm probes
between the TH and F monitoring sites were compared using
the Wilcoxon signed-ranks test. Comparison of the DeO2 and
ReO2 when the VOT was performed at different StO2
deflation thresholds (that is, StO2 of 30%, 40% and 50%)
was performed using the Friedman test and analysis of
variance for repeated measures (after running normality
tests). Results are presented as the median (interquartile
range), P-value unless stated otherwise. Significance reports
a difference between groups corresponding to P <0.05
unless stated otherwise.
Results
Eighteen healthy volunteers were enrolled in the present
study after obtaining informed consent. Demographic charac-
teristics of the studied population are summarized in Table 1.
The mean baseline StO2, DeO2, ReO2 and their coefficients
of variability for these measures for the various comparisons
are summarized in Table 2.
The absolute StO2, DeO2 and ReO2 values for a deflation
threshold of 40% were different between the TH and F for
both the 15 mm and 25 mm probes (Figures 2 and 3), and
were also different at the TH site for the 15 mm and 25 mm
probes (Figure 4). Not surprisingly, the TH DeO2 was not
altered by varying the deflation StO2 thresholds from 30% to
50% when measured with the 15 mm probe. This result was
expected given that the DeO2 is dependent on the metabolic
conditions of the tissue, independent of the intensity of the
ischemic insult and given the specific calculation metho-
dology [1]. If the metabolic rate of the sampled tissue was not
varied, therefore, the DeO2 should not be significantly
modified. The ReO2 was higher using the 30% threshold than
either the 40% or 50% thresholds, which themselves were
similar (Figure 5).
The coefficients of variability for the absolute StO2, DeO2 and
ReO2 values were also different when comparing both sites
and probes, being less with the TH than F measures and with
the 15 mm than 25 mm probe size. We also observed a lower
coefficient of variability with 40% and 50% thresholds as
compared with the 30% threshold (Table 3).
The mean ± standard deviation hyperemic areas under the
curve (Figure 1) as measured by TH15 mm, TH25 mm, F15 mm and
F25 mm were 11.2 ± 8.8%O2/minute, 7.7 ± 5.1%O2/minute,
6.4 ± 5.7%O2/minute and 13.2 ± 9.6%O2/minute, respectively,
and were all significantly different when compared among
each other (Figure 6). Their coefficients of variability were
78.7%, 66.2%, 90.3% and 72.5%, respectively. The
hyperemia durations (mean ± standard deviation) for the
same measurements stated above were 2.3 ± 0.8 minutes,
1.8 ± 0.6 minutes, 1.6 ± 0.5 minutes and 2.8 ± 1.2 minutes,
respectively. These were also statistically different from each
other, as shown in Figure 6. Their coefficients of variability
were 32.9%, 33.5%, 34.1% and 33.5%, respectively.
Discussion
Baseline StO2 values and their emergent parameters of the
DeO2 and the ReO2, assessed by the VOT, are dependent
on the site of measurement, the probe size and, to a certain
extent, the ischaemic challenge. Varying any one of these
components will significantly vary StO2-related measures
independent of the baseline cardiovascular status. When
making inferences about cardiovascular function using these
measures, therefore, care must be taken in comparing or
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Table 1
Demographic characteristics of the study population
Characteristic Value









Weight (kg) 75.5 ± 15.5
Height (cm) 175.8 ± 8.2
Temperature (°C) 36.1 ± 0.6
Systolic blood pressure (mmHg) 118 ± 12
Diastolic blood pressure (mmHg) 73 ± 7
Mean arterial pressure (mmHg) 88 ± 8
Heart rate (beats/minute) 69 ± 9
Data are presented as mean ± standard deviation or n (%).combining results from different studies that use different
measurement techniques and protocols. Presently, the VOT
ischaemic challenge has not been standardized. Several
investigators report the DeO2 and the ReO2 from a fixed
ischaemic time (for example, 3 minutes) rather than to a
defined threshold StO2 value. Since the basal metabolic rate
can vary amongst subjects, varying the DeO2 proportionally
[3] using a fixed ischaemic time will result in differing
threshold StO2 values within and among subjects, making
changes in the ReO2 difficult to interpret among subjects if
their metabolic rates are also different because they will
reach different StO2 nadirs for a constant ischaemic time.
Our data therefore support using a defined ischaemic StO2
threshold in future studies to minimize ReO2 variability.
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Table 2
Baseline tissue oxygen saturation, deoxygenation and reoxygenation rates between sites and between probe sizes
Thenar  Coefficient of  Coefficient of 
Probe eminence variability (%) Forearm variability (%) P valuea
15 mm
Absolute StO2 (%) 90.4 (85.2, 93.5), 76.6 to 95.3b 5.6 85.2 (80.7, 90.2), 65.8 to 93.6b 7.8 0.031
DeO2 (%O2/minute) –12.8 (–16.2, –11.3) 26.1 –8.5 (–10.3, –7.8) 42.7 0.011
ReO2 (%O2/minute) 297.2 (213.7, 328.6) 21.5 98.6 (53.7, 157.8) 68.4 <0.0001
25 mm
Absolute StO2 (%) 92.7 (89.4, 94.7), 81.9 to 95.9b 4.6 87.3 (81.7, 90.9), 76.0 to 95.2b 6.7 0.016
DeO2 (%O2/minute) –18.0 (–24.1, –14.8) 36.5 –9.9 (–15.3, –6.5) 53.6 <0.0001
ReO2 (%O2/minute) 401.6 (331.7, 543.2) 28.2 160.5 (132.3, 366.9) 66.8 0.012




Baseline tissue oxygen saturation (StO2), deoxygenation rate (DeO2) and reoxygenation rate (ReO2) between the thenar eminence versus forearm
and between the 15 mm probe versus 25 mm probe. Data presented as the median (interquartile range). aThenar eminence versus forearm
comparison. bAbsolute StO2 range.
Figure 2
Box plots comparing tissue oxygen saturation (StO2) parameters measured with the 15 mm probe at different anatomical sites. DeO2,
deoxygenation rate; ReO2, reoxygenation rate.We found that the baseline StO2, DeO2 and ReO2 values
were consistently higher in the TH than F sites. Furthermore,
the magnitude of the difference between the TH and F was
greater for DeO2 and ReO2 values than for baseline StO2
values. There was also a trend toward a greater variability for
baseline StO2 at F than at TH sites. This variability was
increased for the DeO2 and ReO2. Although our study does
not allow us to identify why this difference occurs, most
probably it reflects the greater degree of tissue and the
associated vascular variability present in the F over the TH.
The F has a variable layer of subcutaneous fat, which has a
lower metabolic rate and minimal microcirculatory density
when compared with muscle. The TH has almost no fat and is
highly consistent amongst subjects. Our data therefore
support using the TH site rather then the F site when
measuring StO2 and its VOT-related parameters.
Available online http://ccforum.com/content/13/S5/S3
Page 5 of 7
(page number not for citation purposes)
Figure 3
Box plots comparing tissue oxygen saturation (StO2) parameters measured with the 25 mm probe at different anatomical sites. DeO2,
deoxygenation rate; ReO2, reoxygenation rate.
Figure 4
Box plots comparing tissue oxygen saturation (StO2) parameters measured on the thenar eminence with different probes. DeO2, deoxygenation
rate; ReO2, reoxygenation rate.We also found consistently lower baseline StO2 values with
the 15 mm probe than with the 25 mm probe, and this
difference increased with VOT-related parameters. Although
baseline StO2 values displayed a similar variability (5.6% vs.
4.6%), VOT-derived measurements performed with the
15 mm probe showed less variability than those performed
with the 25 mm probe. Presumably, by sampling a smaller
amount of tissue volume, the 15 mm probe is less subject to
measurement error. Our data support the routine use of the
15 mm probe over the 25 mm probe in future studies.
The hyperemic response, as quantified by the area under the
curve and the duration, varied according to the anatomical
site of measurement and the probe size used. Furthermore,
great variability was found among healthy volunteers with
regards to both parameters, as previously pointed out by our
group [9]. These results suggest that the hyperemic
response is not a reproducible parameter, and has been
proven to be highly dependent on individual variability. Thus,
it may not be a reliable parameter for clinical use.
Limitations
The present study has two primary limitations.
First, we studied only two anatomical sites, whereas StO2 can
be measured anywhere on the body. Extrapolation of these
findings to other anatomical sites, such as the abdominal wall,
thigh and masseter muscles, should be done with caution.
Since the VOT can only be carried out realistically on a
peripheral site for which transient ischaemia will have no lasting
deleterious effects, however, these studies reflect the present
clinical practice of near-infrared spectroscopy VOT analysis.
Second, we did not study critically ill patients but healthy
volunteers. Although this was the goal of the study, its
application to critically ill patients might be limited. Previous
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Figure 5
Box plots comparing StO2 parameters measured using different deflation thresholds. DeO2, deoxygenation rate; ReO2, reoxygenation rate.
Table 3
Deoxygenation rate and reoxygenation rate when using different deflation thresholds
Tissue oxygen saturation deflation threshold
Vascular occlusion test parameter 30% 40% 50% P-value
DeO2 (%O2/minute) –14.6 (–18.5, –11.6) –12.8 (–16.2, –11.3) –14.1 (–18.0, –11.9) 0.6
ReO2 (%O2/minute) 319.7 (258.2, 401.5) 297.2 (213.7, 328.6)a 242.5 (211.1, 296.2)a 0.01
Coefficient of variability for DeO2 (%) 34.4 26.1 39.3
Coefficient of variability for ReO2 (%) 30.1 21.5 21.0
Data are presented as the median (interquartile range). DeO2, deoxygenation rate; ReO2, reoxygenation rate. aComparison of ReO2 obtained using
deflation thresholds of 40% and 50% was not significant (P = 0.2).studies by ourselves and others document that cardio-
vascular insufficiency can markedly increase intersubject
variability [4,9]. Our data demonstrated a consistently lower
coefficient of variation whenever the combination of TH site
and 15 mm probe was used, which suggests that this site
may also yield more consistent data in clinical trials. Similarly,
using a defined ischaemic threshold for the VOT, method-
specific variability of the ReO2 should also be minimized.
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Figure 6
Box plot comparison of the hyperemic response between anatomical sites and probe sizes. AUC, hyperemic area under the curve.